Association of peroxisome proliferator‐activated receptor gamma coactivator 1 alpha (PPARGC1A) gene polymorphisms and type 2 diabetes mellitus: a meta‐analysis
Authors:
- 4 February 2011
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 27 (2) , 177-184
Abstract
Background The association between peroxisome proliferator‐activated receptor gamma coactivator 1 alpha (PPARGC1A) polymorphisms and type 2 diabetes mellitus (T2DM) has been investigated in several studies, but these studies yielded contradictory results. We conducted a meta‐analysis to assess the association between three polymorphisms (Gly482Ser, Thr394Thr and Thr612Met) in PPARGC1A and T2DM. Methods A literature‐based search was conducted to collect data. The additive model was chosen to investigate the association between the three polymorphisms and T2DM. The random effects model was used if there was heterogeneity between studies. In addition, subgroup meta‐analyses were made according to the ethnic groups. Results Twenty‐three studies were enrolled in this meta‐analysis (7539 cases and 9562 controls for Gly482Ser, 1818 cases and 2376 controls for Thr394Thr, 2042 cases and 1289 controls for Thr612Met). In the combined analysis of all eligible studies, a significant association was found between Gly482Ser, Thr394Thr and T2DM with pooled odds ratios 1.19 [95% confidence interval (CI) 1.05–1.34] and 1.33 (95% CI 1.04–1.70), respectively, but great heterogeneity was found between studies. In the subgroup meta‐analyses, we found that Gly482Ser and Thr394Thr polymorphisms were associated with the risk of T2DM, and the pooled odds ratios were 1.66 (95% CI 1.28–2.15) and 1.72 (95% CI 1.45–2.03), respectively, in the Indian population; no significant evidence was found in the Caucasian and East Asian populations. Conclusions This meta‐analysis indicated that Gly482Ser and Thr394Thr polymorphisms of PPARGC1A gene were significantly associated with the risk of T2DM, especially in the Indian population. No relationship was found between the Thr612Met and risk of T2DM. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 30 references indexed in Scilit:
- Global estimates of the prevalence of diabetes for 2010 and 2030Diabetes Research and Clinical Practice, 2010
- Linkage and Association Studies of the Susceptibility Genes for Type 2 DiabetesYi chuan xue bao = Acta genetica Sinica, 2006
- Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypesDiabetologia, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- A Gly482Ser Missense Mutation in the Peroxisome Proliferator-Activated Receptor γ Coactivator-1 Is Associated With Altered Lipid Oxidation and Early Insulin Secretion in Pima IndiansDiabetes, 2003
- Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1Nature, 2001
- CREB regulates hepatic gluconeogenesis through the coactivator PGC-1Nature, 2001
- Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1Proceedings of the National Academy of Sciences, 2001
- Globalization, coca‐colonization and the chronic disease epidemic: can the Doomsday scenario be averted?Journal of Internal Medicine, 2000
- Bias in meta-analysis detected by a simple, graphical testBMJ, 1997